Immunization With NY-ESO-1 Protein Combined With CpG 7909 in Patients With Prostate Cancer

NCT00292045 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

BIOLOGICAL: NY-ESO-1 protein/CpG 7909

Sponsor

Ludwig Institute for Cancer Research